Answers are grounded in this paper and cite their sources.
We report time-series evidence on the effects of expansion of Medicaid coverage under the 2014 Affordable Care Act (ACA), on healthcare and outcomes for persons with diabetes, including medium- and longer-term effects. We focus on diabetes, as a common, often-underdiagnosed condition for which effective treatments exist, and on childless adults, who were a particular target for ACA expansion. We use difference-in-differences (DiD) analysis applied to a longitudinal, uniquely detailed (relative to prior work) dataset that includes visit-level electronic healthcare records over 2011–2022 from the Medical College of Wisconsin (a major Milwaukee-centered health system) linked to Medicaid enrollment records. We compare a treatment group of 1,679 newly enrolled childless adults with diabetes to a propensity-score-balanced control group of 1,600 already-insured adults with diabetes (mostly parents with children at home). Gaining insurance leads to sharply higher utilization (outpatient, emergency department, and hospitalization); and large increases in new diagnoses of diabetes and other chronic conditions; related prescriptions; and testing rates. We find improvement in intermediate health outcomes (blood sugar, blood pressure, and cholesterol levels), and suggestive evidence of improved longer-term outcomes (macrovascular events; advanced kidney disease; amputations). We also compare persons with diabetes to other persons; DiD coefficients are generally larger for persons with diabetes, but percentage changes are often higher for other persons.
No takes yet. Share an insight, caveat, or question.
Farzana et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: